News by community
26.03.2020 Biomapas appoints Chief Business Officer
Biomapas appoints Chief Business Officer
March 2020 – Sebastien Duval joins Biomapas as Chief Business Officer to lead the business development department and extend Biomapas continued growth in the global life science industry.
With offices located in Lithuania, Switzerland, Sweden, Russia, Georgia, Ukraine and Poland, Biomapas provides services in 60+ countries across 4 continents. As clinical, regulatory and pharmacovigilance solution provider, Biomapas continues to strengthen its global team and further increases capabilities for extensive growth.
Sebastien Duval brings over 20 years of experience in the life science industry, previously acting as VP Sales Account Management at IQVIA, and further back in his career working as VP Business Development at Synteract, Executive Director, Global Head of Clinical Phase II-IV Business Development at QPS and as VP European Business Development at Premier Research.
“I am thrilled to join Biomapas – the company has an excellent reputation, great teams both in Sales and Operations. There is an increasing need for niche service providers as Biomapas offering clinical research, pharmacovigilance and regulatory solutions of excellence: we have to better serve our customers with standalone expertise at the regional level. It is going to be an exciting journey,” said Sebastien Duval, Biomapas CBO.
Sales driven leader in the global market, Sebastien Duval will lead business development and marketing teams, implement Biomapas strategic goals and ensure the geographical expansion of functional and full outsourcing solutions in the new markets. Sebastien will play a significant role in the extension of service portfolio and strong leadership of overall business development activities.
“At Biomapas, we believe that our team is one of the core elements of our success, and Sebastien joining Biomapas strengthens this element even more. He is an exceedingly talented leader with the focus of our values and future goals for long-term growth. Sebastien brings world-class experience with the broad track record of success, demonstrating his in-depth knowledge and professionalism in the life science industry, “ said Audrius Sveikata, Biomapas CEO.
Sebastien Duval graduated from the University of Poitiers with a specialization in Pharmacology and HEC Paris International Business school with an MBA degree. Since 2000, he works in the life science industry concentrating on business development and management of clinical drug development. As a business development professional, Sebastien Duval has in-depth experience in pre-clinical, bioanalytical, clinical Phase I and Phases II-IV trials within pharma and biotech companies.
Biomapas is a functional and full outsourcing solution provider to the global life science industry, with key expertise in Clinical Trials, Regulatory Affairs and Pharmacovigilance. The company has a significant presence across the CEE, Nordic and CIS countries thereby offering fast and reliable patient recruitment for Phase I-IV and medical device clinical trials, while regulatory and pharmacovigilance services are provided across 4 continents. We are committed to customer service and satisfaction.